# Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With Glioma

> **NCT04114370** · EARLY_PHASE1 · COMPLETED · sponsor: **James Mountz** · enrollment: 9 (actual)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** 18F-fluciclovine

## Key facts

- **NCT ID:** NCT04114370
- **Lead sponsor:** James Mountz
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-22
- **Primary completion:** 2021-05-18
- **Final completion:** 2021-09-30
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2022-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04114370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04114370, "Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With Glioma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04114370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*